Fanaze 150mg Capsules

160

Description

Fanaze 150mg Capsules Indications

  • Fanaze 150mg Capsules is primarily indicated in conditions like Adjunctive therapy without valproate, Candidiasis, Cryptcoccal meningitis, Fungal infection, Neurogenic bladder, Oropharangeal candidiasis, Parkinsonism, Pityriasis versicolor, Vaginal infections, and can also be given in adjunctive therapy as an alternative drug of choice in Bone marrow transplantation, Cryptococcal infections including meningitis, Esophagitis, Urinary tract infection.

Side Effects

  •  The severe or irreversible adverse effects of Fanaze 150mg Capsules, which give rise to further complications include Alopecia, Thrombocytopenia, Elevated alkaline phosphatase concentration, Eelvated hepatic enzymes, Hyperlipidemia, Elevated alkaline phosphatase concentration.,Fanaze 150mg Capsules produces potentially life-threatening effects which include Severe skin reactions in AIDS, Hepatic necrosis, Death, which are responsible for the discontinuation of Fanaze 150mg Capsules therapy., The signs and symptoms that are produced after the acute overdosage of Fanaze 150mg Capsules include Hallucinations, Paranoid psychosis., The symptomatic adverse reactions produced by Fanaze 150mg Capsules are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Nausea, vomiting, Diarrhea, Abdominal pain, Rashes, Hypokalemia, Pallor, Anaphylaxis, Leucopenia, dizziness.

Contraindication

  •  No data regarding the contra indications of Fanaze 150mg Capsules is available.

Warning

  • Fanaze 150mg Capsules should be used with caution in patients with liver disease, kidney disease or of any drug allergy. This medication should be used only when clearly needed during pregnancy. Avoid Fanaze 150mg Capsules during lactation.childern not recommended under one year.Dose adjusted in renal impairment.

Reviews

There are no reviews yet.

Be the first to review “Fanaze 150mg Capsules”

Your email address will not be published. Required fields are marked *